- Home
- CORT vs GGAL Comparison
CORT vs GGAL Comparison
Compare CORT & GGAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- GGAL
- Stock Information
- Founded
- CORT 1998
- GGAL 1905
- Country
- CORT United States
- GGAL Argentina
- Employees
- CORT N/A
- GGAL N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- GGAL Commercial Banks
- Sector
- CORT Health Care
- GGAL Finance
- Exchange
- CORT Nasdaq
- GGAL Nasdaq
- Market Cap
- CORT 7.5B
- GGAL 10.0B
- IPO Year
- CORT N/A
- GGAL N/A
- Fundamental
- Price
- CORT $73.22
- GGAL $50.05
- Analyst Decision
- CORT Strong Buy
- GGAL Strong Buy
- Analyst Count
- CORT 4
- GGAL 4
- Target Price
- CORT $142.00
- GGAL $59.00
- AVG Volume (30 Days)
- CORT 1.9M
- GGAL 1.6M
- Earning Date
- CORT 07-28-2025
- GGAL 01-01-0001
- Dividend Yield
- CORT N/A
- GGAL 3.27%
- EPS Growth
- CORT 8.36
- GGAL 29.31
- EPS
- CORT 1.14
- GGAL 0.85
- Revenue
- CORT $685,446,000.00
- GGAL $5,277,001,683.00
- Revenue This Year
- CORT $35.83
- GGAL $2.91
- Revenue Next Year
- CORT $35.24
- GGAL N/A
- P/E Ratio
- CORT $64.14
- GGAL $6.53
- Revenue Growth
- CORT 30.93
- GGAL N/A
- 52 Week Low
- CORT $29.42
- GGAL $23.53
- 52 Week High
- CORT $117.33
- GGAL $74.00
- Technical
- Relative Strength Index (RSI)
- CORT 51.47
- GGAL 38.07
- Support Level
- CORT $72.48
- GGAL $50.06
- Resistance Level
- CORT $77.42
- GGAL $53.45
- Average True Range (ATR)
- CORT 2.61
- GGAL 2.17
- MACD
- CORT 0.27
- GGAL -0.28
- Stochastic Oscillator
- CORT 47.96
- GGAL 24.05
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About GGAL Grupo Financiero Galicia S.A.
Grupo Financiero Galicia SA is a financial service holding company. It provides general banking services, proprietary brand credit card services, personal loans, insurance, and other services. The company's operating business segments are Banks, Ecosistema Naranja X, Insurance, Adjustments, and Other Businesses. It generates maximum revenue from Banks. Geographically its operate in Argentina, Uruguay, and the majority of its revenue comes from Argentina.